eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | polycystic ovary syndrome |
| Symptom | C0948265|metabolic syndrome |
| Sentences | 23 |
| PubMedID- 24592034 | Objective: to identify biochemical factors that serve as predictors for the metabolic syndrome (mets) in patients with polycystic ovary syndrome (pcos) and to investigate the value of adipocytokines in the prediction of metabolic syndrome. |
| PubMedID- 20925278 | The prevalence of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 21550088 | Both vitamin d deficiency and polycystic ovary syndrome (pcos) are associated with aspects of metabolic syndrome, but it is unclear whether vitamin d deficiency contributes to the metabolic disturbances commonly found in women with pcos. |
| PubMedID- 20396356 | Objective: to study characteristics of the metabolic syndrome (ms) in patients with polycystic ovary syndrome (pcos) according to 2004 diagnostic criteria by the chinese diabetes society (cds). |
| PubMedID- 20852028 | Objective: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome. |
| PubMedID- 22985575 | Association of fat distribution with metabolic syndrome in patients with polycystic ovary syndrome. |
| PubMedID- 21956415 | Context: polycystic ovary syndrome (pcos) is associated with the metabolic syndrome and, consequently, with a potentially increased risk of cardiovascular disease (cvd) and related mortality later in life. |
| PubMedID- 23426706 | Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 21277789 | Women of reproductive age are not spared from the complications of metabolic syndrome, which overlaps with obesity and polycystic ovary syndrome (pcos), both of which are linked to infertility and poor reproductive outcome. |
| PubMedID- 21114431 | Background: both non-alcoholic steatohepatitis (nash) and polycystic ovary syndrome (pcos) are associated with metabolic syndrome (ms) and insulin resistance (ir). |
| PubMedID- 21251033 | Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. |
| PubMedID- 20540665 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome, using two proposed definitions. |
| PubMedID- 20807165 | metabolic syndrome in adolescents with polycystic ovary syndrome. |
| PubMedID- 22870011 | Objective: the aim of the present study was to evaluate the prevalence of metabolic syndrome in women with polycystic ovary syndrome (pcos). |
| PubMedID- 26488852 | Targets to treat metabolic syndrome in polycystic ovary syndrome. |
| PubMedID- 23885694 | Age- and body mass index-related differences in the prevalence of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 22888988 | Prevalence of metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 23283052 | Objective: the aim of this study was to assess the association between premicroalbuminuria and metabolic syndrome in women with polycystic ovary syndrome (pcos). |
| PubMedID- 21450287 | Objective: to determine prevalence of metabolic syndrome in adolescents with polycystic ovary syndrome (pcos) and derive features suggestive of propensity for development of metabolic syndrome. |
| PubMedID- 20199774 | Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 21756079 | Objective: based on the role of polycystic ovary syndrome as a cause of metabolic syndrome with chronic anovulation, obesity, hyperinsulinemia and hyperandrogenism, development of effective treatment for its obesity is a priority. |
| PubMedID- 23656383 | Cigarette smoking, nicotine levels and increased risk for metabolic syndrome in women with polycystic ovary syndrome. |
| PubMedID- 21962027 | polycystic ovary syndrome (pcos) is associated with the metabolic syndrome (mets). |
Page: 1